0000000000372730

AUTHOR

Pedro Navalón

showing 4 related works from this author

Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis

2017

Adenosine is a potent regulator of inflammation and immunity, but the role of adenosine receptors in keratinocytes remains controversial. We determined that in addition to A2B receptors, human epidermal keratinocytes also express A2A receptors, although to a lower extent. Through the use of selective adenosine receptor agonists and antagonists, we showed that physiological concentrations of adenosine activate A2B receptors in normal human keratinocytes, inducing cell cycle arrest through the increase of intracellular calcium but not through cAMP signaling. In contrast, the selective activation of A2A receptors by CGS-21680 induces keratinocyte proliferation via p38–mitogen-activated protein…

keratinocytes0301 basic medicinemedicine.medical_specialtyAdenosinepsoriatic epidermisDermatologyBiologyBiochemistry03 medical and health scienceschemistry.chemical_compoundInternal medicinemedicineReceptorMolecular BiologyCGS-21680human epidermal keratinocytesMRS-1706Cell BiologyPurinergic signallingAdenosine A3 receptorAdenosine receptorAdenosineCell biology030104 developmental biologyEndocrinologymedicine.anatomical_structurechemistryKeratinocytemedicine.drugJournal of Investigative Dermatology
researchProduct

β2-adrenoreceptors control human skin microvascular reactivity.

2021

Topical α1- and α2-adrenoreceptor (ADRA1 and 2) agonists are effective in alleviating permanent vasodilation and facial erythema associated with rosacea by inducing skin vasoconstriction. Although β-adrenoreceptor (ADRB) antagonists are used off-label for rosacea, pharmacological and pharmacodynamic data pertaining to these receptors in skin micro-vessels are lacking. Objectives: To analyse the expression of different adrenergic receptors and their contribution to vasoreactivity in skin micro-vessels. Small arteries (500-800 μm) and arterioles (<200 μm) were studied in human foreskin tissue. Specifically, ADR-A1, -A2, -B1 and -B2 expression was assayed by immunofluorescence, polymerase chai…

AdultMaleAdrenergic receptorAdolescentForeskinVasodilationHuman skinDermatologyPharmacologyYoung AdultReceptors Adrenergic alpha-2medicinePrazosinHumansRNA Messengerintegumentary systembusiness.industryBrimonidineArteriesVasodilationArteriolesmedicine.anatomical_structureReceptors Adrenergic beta-2medicine.symptombusinessPerfusionVasoconstrictionmedicine.drugArteryEuropean journal of dermatology : EJD
researchProduct

NF-κB and STAT3 Inhibition as a Therapeutic Strategy in Psoriasis: In Vitro and In Vivo Effects of BTH

2013

Benzo[b]thiophen-2-yl-3-bromo-5-hydroxy-5H-furan-2-one (BTH) is a simple and interesting synthetic derivative of petrosaspongiolide M, a natural compound isolated from a sea sponge with demonstrated potent anti-inflammatory activity through inhibition of the NF-κB signaling pathway. In the present study, we report the in vitro and in vivo pharmacological effect of BTH on some parameters related to the innate and adaptive response in the pathogenesis of psoriasis. BTH inhibited the release of some of the key psoriatic cytokines such as tumor necrosis factor α, IL-8, IL-6, and CCL27 through the downregulation of NF-κB in normal human keratinocytes. Moreover, it impaired signal transducers and…

KeratinocytesMaleSTAT3 Transcription FactorForeskinPrimary Cell CultureDermatitisInflammationDermatologyPharmacologyBiochemistryMicechemistry.chemical_compoundIn vivoPsoriasisThiadiazolesmedicineAnimalsHumansPsoriasisSTAT3Molecular BiologyCell ProliferationMice Inbred BALB CbiologyNF-kappa BNF-κBCell Biologymedicine.diseaseDisease Models Animalmedicine.anatomical_structurechemistrybiology.proteinCytokinesFemaleCCL27Signal transductionmedicine.symptomKeratinocyteJournal of Investigative Dermatology
researchProduct

Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-κB and STAT3 in human keratinocytes

2012

Abstract Chondroitin sulfate (CS) is a natural glycosaminoglycan, formed by the 1–3 linkage of d -glucuronic acid to N-acetylgalactosamine, present in the extracellular matrix. It is used as a slow acting disease modifying agent in the treatment of osteoarthritis, and part of its beneficial effects are due to its antiinflammatory properties that result from an inhibitory effect on NF-κB signaling pathway. This ability raises the hypothesis that CS might be effective in other chronic inflammatory processes such as psoriasis, in which a deregulation of NF-κB is a key feature. In addition, psoriasis is characterized by an upregulation of STAT3 signaling pathway that is related to the epidermal…

KeratinocytesSTAT3 Transcription FactorBlotting WesternPrimary Cell CultureAnti-Inflammatory AgentsDermoscopyElectrophoretic Mobility Shift AssayPharmacologyStat3 Signaling Pathwaychemistry.chemical_compoundDownregulation and upregulationPsoriasismedicineHumansPsoriasisChondroitin sulfateCells CulturedPharmacologyChemistryChondroitin SulfatesNF-kappa BNF-κBmedicine.diseaseMicroscopy FluorescenceImmunologyPhosphorylationTumor necrosis factor alphaSignal transductionProtein BindingPharmacological Research
researchProduct